Industry Slams Brazilian Plans To Change Importation Rules
Move Could Disadvantage Local Manufacturers And Risk Patient Safety
Executive Summary
Industry representatives are at odds with the Brazilian medicines regulator and health ministry over plans to change the regulations on importing unregistered medicines in exceptional circumstances.